Neuland Laboratories Limited announced that the Board of Directors in their meeting held May 8, 2015, the board of directors approved the appointment of Dr. Nirmala Murthy as an Additional Director on the Board of the company effective May 8, 2015 and the appointment of Mr. Anil Kumar as Chief Financial officer of the company u/s 203 of the Companies Act, 2013 in place of Mr. N. S. Viswanathan, CFO, whose resignation has been approved with effect from May 8, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,246 INR | +4.11% | +0.97% | +18.13% |
May. 14 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 | |
May. 10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.13% | 921M | |
+42.51% | 750B | |
+34.11% | 606B | |
-6.25% | 356B | |
+18.79% | 326B | |
+6.32% | 286B | |
+18.49% | 246B | |
-3.31% | 213B | |
+11.30% | 213B | |
+2.14% | 167B |
- Stock Market
- Equities
- NEULANDLAB Stock
- News Neuland Laboratories Limited
- Neuland Laboratories Limited Approves Management Changes